Return to Search
EN
Precancerous changes in the cervix detected by a Pap smear are classified based on the severity and degree of the abnormality. The classifications are as follows:
ASCUS (Atypical Squamous Cells of Undetermined Significance):
This diagnosis indicates that the cells collected during the Pap smear show some abnormalities, but these changes are not clearly indicative of precancerous lesions. The pathologist suspects atypical cells but cannot definitively classify them as dysplastic.
While ASCUS does not confirm a cellular abnormality, further evaluation is warranted. Instead of waiting a full year for a repeat Pap smear, a follow-up smear is typically recommended within 2-3 months.
Alternatively, a colposcopy, which involves a detailed examination of the cervix under magnification, may be performed. If any suspicious areas are identified during colposcopy, a cervical biopsy (removal of a small tissue sample) may be taken for definitive diagnosis.
Furthermore, HPV (Human Papilloma Virus) typing can be conducted in ASCUS cases to assess the significance of the finding. The results of HPV typing can guide further management decisions, including whether to proceed with colposcopy or to discuss HPV vaccination.
Waiting 2-3 months for a repeat smear generally poses no harm, as the condition is unlikely to progress significantly during this period.
LSIL (Low-Grade Squamous Intraepithelial Lesion):
LSIL indicates the presence of mild cellular abnormalities, suggesting low-grade precancerous changes. It is important to note that an LSIL diagnosis does not mean the patient has cervical cancer.
In approximately 90% of cases, particularly in individuals with a healthy immune system, LSIL spontaneously regresses without intervention. However, in about 10% of cases, especially in patients who neglect follow-up appointments or have a compromised immune system, the condition may progress to a higher-grade lesion (HSIL).
Patients diagnosed with LSIL typically undergo colposcopy for a detailed examination of the cervix. If suspicious areas are identified, thin tissue samples are taken via cervical biopsy for further histological analysis. This procedure may cause some discomfort but generally does not require anesthesia.
HSIL (High-Grade Squamous Intraepithelial Lesion):
HSIL signifies the presence of more significant cellular abnormalities, indicating high-grade precancerous changes that carry a higher risk of progression to cervical cancer if left untreated.
A colposcopy is mandatory for all HSIL diagnoses to identify the abnormal areas. Tissue samples must be taken from these areas via biopsy for definitive histological diagnosis. The subsequent management plan will be determined based on the biopsy report.
How is a Pap Smear Test Result Evaluated?
ASCUS (Atypical Squamous Cells of Undetermined Significance):
This diagnosis indicates that the cells collected during the Pap smear show some abnormalities, but these changes are not clearly indicative of precancerous lesions. The pathologist suspects atypical cells but cannot definitively classify them as dysplastic.
While ASCUS does not confirm a cellular abnormality, further evaluation is warranted. Instead of waiting a full year for a repeat Pap smear, a follow-up smear is typically recommended within 2-3 months.
Alternatively, a colposcopy, which involves a detailed examination of the cervix under magnification, may be performed. If any suspicious areas are identified during colposcopy, a cervical biopsy (removal of a small tissue sample) may be taken for definitive diagnosis.
Furthermore, HPV (Human Papilloma Virus) typing can be conducted in ASCUS cases to assess the significance of the finding. The results of HPV typing can guide further management decisions, including whether to proceed with colposcopy or to discuss HPV vaccination.
Waiting 2-3 months for a repeat smear generally poses no harm, as the condition is unlikely to progress significantly during this period.
LSIL (Low-Grade Squamous Intraepithelial Lesion):
LSIL indicates the presence of mild cellular abnormalities, suggesting low-grade precancerous changes. It is important to note that an LSIL diagnosis does not mean the patient has cervical cancer.
In approximately 90% of cases, particularly in individuals with a healthy immune system, LSIL spontaneously regresses without intervention. However, in about 10% of cases, especially in patients who neglect follow-up appointments or have a compromised immune system, the condition may progress to a higher-grade lesion (HSIL).
Patients diagnosed with LSIL typically undergo colposcopy for a detailed examination of the cervix. If suspicious areas are identified, thin tissue samples are taken via cervical biopsy for further histological analysis. This procedure may cause some discomfort but generally does not require anesthesia.
HSIL (High-Grade Squamous Intraepithelial Lesion):
HSIL signifies the presence of more significant cellular abnormalities, indicating high-grade precancerous changes that carry a higher risk of progression to cervical cancer if left untreated.
A colposcopy is mandatory for all HSIL diagnoses to identify the abnormal areas. Tissue samples must be taken from these areas via biopsy for definitive histological diagnosis. The subsequent management plan will be determined based on the biopsy report.